Advertising

Press Releases

10135 Press Releases
DateTitleCompany
31 Aug 10 Orthofix International Establishes New $300 Million Credit Facility Orthofix International N.V.,
Published by
Business Wire
31 Aug 10 Continucare Expands Sleep Center Operations with Acquisition of Sleep Diagnostic Operator Continucare Corporation,
Published by
Business Wire
31 Aug 10 LocateADoc.com Launches New Vein Specialty Results for Patients, Doctors LocateADoc.com,
Published by
Business Wire
31 Aug 10 The RSV M37 Clinical Challenge Virus Manufactured by Meridian Life Science® is a Powerful Tool for the Development of New RSV Vaccines and Therapeutics Meridian Life Science Inc.,
Published by
Business Wire
31 Aug 10 GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program Xcellerex Inc.,
Published by
Business Wire
31 Aug 10 Bruker to Ring NASDAQ Opening Bell on Company’s 50th Anniversary Bruker Corporation,
Published by
Business Wire
31 Aug 10 Affymax® Announces Upcoming Webcasts and Conference Participation Affymax Inc.,
Published by
Business Wire
31 Aug 10 Building on a successful launch, the EMAUD market access programme opens enrolment for a second year EMAUD
31 Aug 10 ANGINA DRUG, PROCORALAN, SAVES LIVES OF PATIENTS WITH HEART FAILURE Servier
31 Aug 10 RecipharmCobra Biologics Announces Patent for Novel Antibiotic-Free Plasmid Maintenance System RecipharmCobra Biologics
31 Aug 10 TPP Global Development Ltd Enters into an Agreement with the University of Edinburgh for Future Drug Development TPP Global Development Ltd,
Published by
Business Wire
31 Aug 10 Dr Klaus Wiedey Reappointed Managing Director and CEO Europe at Ecron Acunova (EA) Ecron Acunova,
Published by
Business Wire
31 Aug 10 Synexus Welcomes a New Chief Executive and Gears up for Its Next Phase of Growth Synexus,
Published by
Business Wire
31 Aug 10 Ipsen’s Half-year 2010 Results Ipsen S.A.,
Published by
Business Wire
31 Aug 10 Achaogen Awarded Contract Worth up to $64 Million by BARDA for the Development of ACHN-490 Achaogen,
Published by
Business Wire
31 Aug 10 Furiex Pharmaceuticals, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York September 12-15, 2010 Furiex Pharmaceuticals Inc.,
Published by
Business Wire
31 Aug 10 Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study Johnson & Johnson Pharmaceutical Research & Development L.L.C.,
Published by
Business Wire
31 Aug 10 Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2010 Hi-Tech Pharmacal Co. Inc.,
Published by
Business Wire
31 Aug 10 Elan Corporation plc Announces Commencement of Asset Sale Offer to Purchase up to $186,000,000 of 8 7/8% Senior Fixed Rate Notes Due 2013 and Floating Rate Notes Due 2013 Elan Corporation plc,
Published by
Business Wire
31 Aug 10 Research and Markets: Pharmaceutical M&A in the Asia-Pacific Region - India and China Drive Regional Activity but Japan Still Dominates High Value Transactions Research and Markets,
Published by
Business Wire
31 Aug 10 Research and Markets: Japan Pharmaceutical Market Overview Regulatory Reforms will Stimulate Generics Uptake Research and Markets,
Published by
Business Wire
31 Aug 10 Research and Markets: Commercial Insight: Inflammatory Bowel Disease - Future Market Prospects Rely on Addressing Cost and Safety Research and Markets,
Published by
Business Wire
31 Aug 10 Salix Pharmaceuticals Announces Settlement of Pending Litigation Regarding MOVIPREP® Salix Pharmaceuticals Ltd.,
Published by
Business Wire
30 Aug 10 Sebelius Announces 1 Million Medicare Beneficiaries Have Received Prescription Drug Cost Relief under the Affordable Care Act U.S. Department of Health and Human Services,
Published by
Business Wire
30 Aug 10 KYTHERA and Bayer Dermatology Unit Intendis Enter Licensing and Development Agreement for Adipolytic Agent ATX-101 KYTHERA Biopharmaceuticals Inc.,
Published by
Business Wire
30 Aug 10 BARDA Funds Drug Development for Biothreats, Antibiotic Resistance U.S. Department of Health and Human Services,
Published by
Business Wire
30 Aug 10 Research and Markets: This Onychomycosis Therapy Area Pipeline Report Contains Detailed Information on the Onychomycosis Drug Pipeline Research and Markets,
Published by
Business Wire
30 Aug 10 Ramsell Public Health Rx Secures Delaware ADAP Contract Ramsell Public Health Rx,
Published by
Business Wire
30 Aug 10 Research and Markets: Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of Legal, Productivity, and Quality Control Issues Research and Markets,
Published by
Business Wire
30 Aug 10 Advanced Cell Technology’s Robust Cell Reprogramming/Transdifferentiation Platform Well Positioned To Capitalize on Emerging Trends in Regenerative Medicine Advanced Cell Technology Inc.,
Published by
Business Wire
Advertising